{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T01:32:30Z","timestamp":1791941550795,"version":"4.3.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"AstraZeneca"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Health Econ"],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Introduction<\/jats:title>\n            <jats:p>Asthma is a prevalent chronic respiratory condition that significantly impacts public health, with severe asthma subtypes, such as severe eosinophilic asthma, imposing substantial socioeconomic burdens.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Real-world data from the Italian Health Information System were analyzed to evaluate the economic consequences of asthma in Italy. An in-depth comparative analysis was conducted to investigate the economic implications of various asthma subtypes, focusing on severe eosinophilic asthma. Additionally, the study projected the potential cost-effectiveness of novel treatments aimed at reducing hospitalization rates, specialist visits, and oral corticosteroid use for patients with severe eosinophilic asthma in Italy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The analysis revealed that severe asthma, and notably severe eosinophilic asthma, places a substantial economic burden on the Italian National Health System. Estimates demonstrated that implementing innovative treatments to mitigate the risks of hospitalization and specialist visits, as well as reducing oral corticosteroid usage in severe eosinophilic asthma patients, could lead to significant cost savings. The cost-consequence analysis indicated potential yearly reductions of \u20ac50.0 million (27%) for the treatment of severe asthma and \u20ac31.7 million (26%) for severe eosinophilic asthma.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>This study presents a comprehensive evaluation of the economic repercussions of severe asthma in Italy. The findings emphasize the necessity of identifying and developing effective therapeutic strategies to improve the management of severe asthma while simultaneously reducing the economic burden on the healthcare system. These results offer valuable insights for healthcare policymakers and practitioners, facilitating evidence-based decisions in asthma management and healthcare policy in Italy.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s10198-024-01736-5","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T01:57:36Z","timestamp":1734487056000},"page":"869-876","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The economic burden of asthma in Italy: evaluating the potential impact of different treatments in adult patients with severe eosinophilic asthma"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6413-7706","authenticated-orcid":false,"given":"Matteo","family":"Scortichini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco Saverio","family":"Mennini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Marcellusi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Paoletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Tomino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Sciattella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,18]]},"reference":[{"key":"1736_CR1","unstructured":"Global Burden of Disease Collaborative Network: Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2019 (GBD 2019) Results (2019)"},{"key":"1736_CR2","doi-asserted-by":"crossref","unstructured":"Masoli, M., Fabian, D., Holt, S., Beasley, R.: The global burden of asthma: executive summary of the GINA Dissemination Committee Report (2004)","DOI":"10.1111\/j.1398-9995.2004.00526.x"},{"key":"1736_CR3","unstructured":"Cricelli, C., Brignoli, O., Medea, G., Parretti, D., Lombardo, F.P., Aprile, P.L., Lapi, F., Cricelli, I.: Impatto epidemiologico delle cronicit\u00e0 in Medicina Generale"},{"key":"1736_CR4","doi-asserted-by":"publisher","unstructured":"National Asthma Education: Expert Panel Report 3 (EPR-3): guidelines for the diagnosis and management of asthma-summary report 2007. J Allergy Clin Immunol. 120 (2007). https:\/\/doi.org\/10.1016\/j.jaci.2007.09.029","DOI":"10.1016\/j.jaci.2007.09.029"},{"key":"1736_CR5","unstructured":"GINA: Global Initiative for Asthma\u2014GINA What\u2019s new in GINA 2021? Global Strategy for Asthma Management and Prevention. Ginasthma.org (2021)"},{"key":"1736_CR6","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00202013","author":"KF Chung","year":"2014","unstructured":"Chung, K.F., Wenzel, S.E., Brozek, J.L., Bush, A., Castro, M., Sterk, P.J., Adcock, I.M., Bateman, E.D., Bel, E.H., Bleecker, E.R., Boulet, L.P., Brightling, C., Chanez, P., Dahlen, S.E., Djukanovic, R., Frey, U., Gaga, M., Gibson, P., Hamid, Q., Jajour, N.N., Mauad, T., Sorkness, R.L., Teague, W.G.: International ERS\/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur. Respir. J. (2014). https:\/\/doi.org\/10.1183\/09031936.00202013","journal-title":"Eur. Respir. J."},{"key":"1736_CR7","doi-asserted-by":"publisher","DOI":"10.23822\/EurAnnACI.1764-1489.69","author":"C Micheletto","year":"2018","unstructured":"Micheletto, C., Bil\u00f2, M.B., Antonicelli, L., Bresciani, M., D\u2019amato, G., de Benedictis, E., de Michele, F., Gasparini, S., Giovannini, M., Musarra, A., Vaghi, A.: Severe asthma in adolescents and adults: a national, multicenter registry in real life. Eur. Ann. Allergy Clin. Immunol. (2018). https:\/\/doi.org\/10.23822\/EurAnnACI.1764-1489.69","journal-title":"Eur. Ann. Allergy Clin. Immunol."},{"key":"1736_CR8","doi-asserted-by":"publisher","DOI":"10.23822\/EurAnnACI.1764-1489.196","author":"MB Bil\u00f2","year":"2021","unstructured":"Bil\u00f2, M.B., Antonicelli, L., Carone, M., de Michele, F., Menzella, F., Musarra, A., Tognella, S., Vaghi, A., Micheletto, C.: Severe asthma management in the era of biologics: insights of the italian registry on severe asthma (irsa). Eur. Ann. Allergy Clin. Immunol. (2021). https:\/\/doi.org\/10.23822\/EurAnnACI.1764-1489.196","journal-title":"Eur. Ann. Allergy Clin. Immunol."},{"key":"1736_CR9","doi-asserted-by":"publisher","DOI":"10.1111\/all.13342","author":"S Maio","year":"2018","unstructured":"Maio, S., Baldacci, S., Bresciani, M., Simoni, M., Latorre, M., Murgia, N., Spinozzi, F., Braschi, M., Antonicelli, L., Brunetto, B., Iacovacci, P., Roazzi, P., Pini, C., Pata, M., la Grasta, L., Paggiaro, P., Viegi, G., Angino, A., Carrozzi, L., Cerrai, S., di Pede, F., Martini, F., Pala, A.P., Pistelli, F., Sarno, G., Silvi, P., Novelli, F., Ferri, M., Bonifazi, F., Viegi, G.: RItA: The Italian severe\/uncontrolled asthma registry. Allergy Eur. J. Allergy Clin. Immunol. (2018). https:\/\/doi.org\/10.1111\/all.13342","journal-title":"Allergy Eur. J. Allergy Clin. Immunol."},{"key":"1736_CR10","doi-asserted-by":"publisher","DOI":"10.5415\/apallergy.2020.10.e14","author":"M Nagata","year":"2020","unstructured":"Nagata, M., Nakagome, K., Soma, T.: Mechanisms of eosinophilic inflammation. Asia Pac. Allergy (2020). https:\/\/doi.org\/10.5415\/apallergy.2020.10.e14","journal-title":"Asia Pac. Allergy"},{"key":"1736_CR11","doi-asserted-by":"crossref","unstructured":"Melo, R.C.N., Weller, P.F.: Contemporary understanding of the secretory granules in human eosinophils (2018)","DOI":"10.1002\/JLB.3MR1217-476R"},{"key":"1736_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/9780470694923","volume-title":"Asthma and Rhinitis","author":"WW Busse","year":"2000","unstructured":"Busse, W.W., Holgate, S.T.: Asthma and Rhinitis. Blackwell Science, New York (2000)"},{"key":"1736_CR13","doi-asserted-by":"publisher","DOI":"10.2147\/JAA.S97973","author":"D Price","year":"2016","unstructured":"Price, D., Wilson, A.M., Chisholm, A., Rigazio, A., Burden, A., Thomas, M., King, C.: Predicting frequent asthma exacerbations using blood eosinophil count and other patient data routinely available in clinical practice. J Asthma Allergy (2016). https:\/\/doi.org\/10.2147\/JAA.S97973","journal-title":"J Asthma Allergy"},{"key":"1736_CR14","doi-asserted-by":"publisher","first-page":"00024","DOI":"10.1183\/23120541.00024-2015","volume":"1","author":"JC de Groot","year":"2015","unstructured":"de Groot, J.C., ten Brinke, A., Bel, E.H.D.: Management of the patient with eosinophilic asthma: a new era begins. ERJ Open Res. 1, 00024 (2015)","journal-title":"ERJ Open Res."},{"key":"1736_CR15","doi-asserted-by":"crossref","unstructured":"Loftus, P.A., Wise, S.K.: Epidemiology and economic burden of asthma (2015)","DOI":"10.1002\/alr.21547"},{"key":"1736_CR16","doi-asserted-by":"publisher","DOI":"10.2147\/JAA.S176026","author":"DB Price","year":"2018","unstructured":"Price, D.B., Trudo, F., Voorham, J., Xu, X., Kerkhof, M., Jie, J.L.Z., Tran, T.N.: Adverse outcomes from initiation of systemic corticosteroids for asthma: long-term observational study. J. Asthma Allergy (2018). https:\/\/doi.org\/10.2147\/JAA.S176026","journal-title":"J. Asthma Allergy"},{"key":"1736_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2017.04.009","author":"PW Sullivan","year":"2018","unstructured":"Sullivan, P.W., Ghushchyan, V.H., Globe, G., Schatz, M.: Oral corticosteroid exposure and adverse effects in asthmatic patients. J. Allergy Clin. Immunol. (2018). https:\/\/doi.org\/10.1016\/j.jaci.2017.04.009","journal-title":"J. Allergy Clin. Immunol."},{"key":"1736_CR18","doi-asserted-by":"crossref","unstructured":"Perez-de-Llano, L., Tran, T.N., Al-ahmad, M., Alacqua, M., Bulathsinhala, L., Busby, J., Canonica, G.W., Carter, V., Chaudhry, I., Christoff, G.C., Cosio, B.G., Costello, R.W., Fitzgerald, J.M., Heaney, L.G., Heffler, E., Iwanaga, T., Jackson, D.J., Kerkhof, M., Rhee, C.K., Menzies-Gow, A., Murray, R., Papadopoulos, N.G., Papaioannou, A.L., Pfeffer, P.E., Popov, T.A., Price, C.A., Sadatsafavi, M., Tohda, Y., Wang, E., Wechsler, M., Zangrilli, J.G., Price, D.B.: Characterization of Eosinophilic and Non-Eosinophilic Severe Asthma Phenotypes and Proportion of Patients with These Phenotypes in the International Severe Asthma Registry (ISAR). Presented at the (2020)","DOI":"10.1164\/ajrccm-conference.2020.201.1_MeetingAbstracts.A4525"},{"key":"1736_CR19","doi-asserted-by":"publisher","first-page":"99","DOI":"10.23822\/EurAnnACI.1764-1489.203","volume":"53","author":"S Maio","year":"2021","unstructured":"Maio, S., Baldacci, S., Cecchi, L., Viegi, G.: The severe asthma registries: a way to better know and fight the disease. Eur. Ann. Allergy Clin. Immunol. 53, 99 (2021)","journal-title":"Eur. Ann. Allergy Clin. Immunol."},{"key":"1736_CR20","doi-asserted-by":"crossref","unstructured":"Heaney, L.G., Perez de Llano, L., Al-Ahmad, M., Backer, V., Busby, J., Canonica, G.W., Christoff, G.C., Cosio, B.G., FitzGerald, J.M., Heffler, E., Iwanaga, T., Jackson, D.J., Menzies-Gow, A.N., Papadopoulos, N.G., Papaioannou, A.I., Pfeffer, P.E., Popov, T.A., Porsbjerg, C.M., Rhee, C.K., Sadatsafavi, M., Tohda, Y., Wang, E., Wechsler, M.E., Alacqua, M., Altraja, A., Bjermer, L., Bj\u00f6rnsd\u00f3ttir, U.S., Bourdin, A., Brusselle, G.G., Buhl, R., Costello, R.W., Hew, M., Koh, M.S., Lehmann, S., Lehtim\u00e4ki, L., Peters, M., Taill\u00e9, C., Taube, C., Tran, T.N., Zangrilli, J., Bulathsinhala, L., Carter, V.A., Chaudhry, I., Eleangovan, N., Hosseini, N., Kerkhof, M., Murray, R.B., Price, C.A., Price, D.B.: Eosinophilic and noneosinophilic asthma: an expert consensus framework to characterize phenotypes in a global real-life severe asthma cohort. In: Chest (2021)","DOI":"10.1016\/j.chest.2021.04.013"},{"key":"1736_CR21","doi-asserted-by":"publisher","DOI":"10.2307\/2276774","author":"EB Wilson","year":"1927","unstructured":"Wilson, E.B.: Probable inference, the law of succession, and statistical inference. J. Am. Stat. Assoc. (1927). https:\/\/doi.org\/10.2307\/2276774","journal-title":"J. Am. Stat. Assoc."},{"key":"1736_CR22","doi-asserted-by":"publisher","DOI":"10.1111\/1467-9639.00050","author":"RW Johnson","year":"2001","unstructured":"Johnson, R.W.: An introduction to the bootstrap. Teach. Stat. (2001). https:\/\/doi.org\/10.1111\/1467-9639.00050","journal-title":"Teach. Stat."},{"key":"1736_CR23","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12931-023-02439-w","volume":"24","author":"A Vultaggio","year":"2023","unstructured":"Vultaggio, A., Aliani, M., Altieri, E., Bracciale, P., Brussino, L., Caiaffa, M.F., Cameli, P., Canonica, G.W., Caruso, C., Centanni, S., D\u2019Amato, M., De Michele, F., Del Giacco, S., Di Marco, F., Menzella, F., Pelaia, G., Rogliani, P., Romagnoli, M., Schino, P., Senna, G., Benci, M., Boarino, S., Schroeder, J.W.: Long-term effectiveness of benralizumab in severe eosinophilic asthma patients treated for 96-weeks: data from the ANANKE study. Respir. Res. 24, 135 (2023). https:\/\/doi.org\/10.1186\/s12931-023-02439-w","journal-title":"Respir. Res."},{"key":"1736_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2007.07.011","author":"RW Dal Negro","year":"2007","unstructured":"Dal Negro, R.W., Micheletto, C., Tosatto, R., Dionisi, M., Turco, P., Donner, C.F.: Costs of asthma in Italy: results of the SIRIO (Social Impact of Respiratory Integrated Outcomes) study. Respir. Med. (2007). https:\/\/doi.org\/10.1016\/j.rmed.2007.07.011","journal-title":"Respir. Med."},{"key":"1736_CR25","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201703-259OC","author":"T Nurmagambetov","year":"2018","unstructured":"Nurmagambetov, T., Kuwahara, R., Garbe, P.: The economic burden of asthma in the United States, 2008\u20132013. Ann. Am. Thorac. Soc. (2018). https:\/\/doi.org\/10.1513\/AnnalsATS.201703-259OC","journal-title":"Ann. Am. Thorac. Soc."},{"key":"1736_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12030985","author":"C Vitale","year":"2023","unstructured":"Vitale, C., Maglio, A., Pelaia, C., D\u2019Amato, M., Ciampo, L., Pelaia, G., Molino, A., Vatrella, A.: Effectiveness of benralizumab in OCS-dependent severe asthma: the impact of 2 years of therapy in a real-life setting. J. Clin. Med. (2023). https:\/\/doi.org\/10.3390\/jcm12030985","journal-title":"J. Clin. Med."},{"key":"1736_CR27","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202210_30016","author":"B Sposato","year":"2022","unstructured":"Sposato, B., Scalese, M., Camiciottoli, G., Carpagnano, G.E., Pelaia, C., Santus, P., Pelaia, G., Palmiero, G., Tomassi, M.D.I., Ronchi, M.C., Cameli, P., Bargagli, E., Ciambellotti, L., Rizzello, S., Sglavo, R., Coppola, A., Lacerenza, L.G., Gabriele, M., Radovanovic, D., Perrella, A., Ricci, A., Rogliani, P.: Severe asthma and long-term Benralizumab effectiveness in real-life. Eur. Rev. Med. Pharmacol. Sci. (2022). https:\/\/doi.org\/10.26355\/eurrev_202210_30016","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"1736_CR28","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/all.14494","volume":"76","author":"P Azzano","year":"2021","unstructured":"Azzano, P., Dufresne, \u00c9., Poder, T., B\u00e9gin, P.: Economic considerations on the usage of biologics in the allergy clinic. Allergy 76, 191\u2013209 (2021)","journal-title":"Allergy"},{"key":"1736_CR29","first-page":"4589","volume":"127","author":"J Reibman","year":"2021","unstructured":"Reibman, J., Tan, L., Ambrose, C., Chung, Y., Desai, P., Llanos, J.P., Moynihan, M., Tkacz, J.: Clinical and economic burden of severe asthma among US patients treated with biologic therapies. Ann. Allergy Asthma Immunol.Immunol. 127, 4589 (2021)","journal-title":"Ann. Allergy Asthma Immunol.Immunol."}],"container-title":["The European Journal of Health Economics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10198-024-01736-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10198-024-01736-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10198-024-01736-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T10:18:22Z","timestamp":1751019502000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10198-024-01736-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,18]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["1736"],"URL":"https:\/\/doi.org\/10.1007\/s10198-024-01736-5","relation":{},"ISSN":["1618-7598","1618-7601"],"issn-type":[{"value":"1618-7598","type":"print"},{"value":"1618-7601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,18]]},"assertion":[{"value":"9 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}